
Janus Henderson Global Life Sciences Fund
JAGLX
Updated: 04/11/2026, 12:29:25
No historical data available
The Janus Henderson Global Life Sciences Fund primarily focuses its investment strategy on companies operating within the life sciences field. Typically, at least 80% of its net assets (which includes any borrowed funds for investment) are allocated to firms that the portfolio manager believes exhibit a life sciences orientation. Additionally, as a fundamental investment principle, the fund generally commits a minimum of 25% of its total assets to businesses officially classified within the "life sciences" sector.
No summaries found.
- Share price
- $92.05
- Market cap
- $5.80B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- N/A
- Employees
- N/A
- IPO date
- 31/12/1998
- Beta
- 0.66
- Last dividend
- $0.00
- Day range
- $91.93 – $92.05
- 52-week range
- $74.88 – $93.51
- 1-day performance
- 0.13%
- 1-year performance
- 22.93%
- Current drawdown (1Y)
- -1.56%
- CIK
- 0000277751
- CUSIP
- 471023671
- ISIN
- US4710236716
- Created
- 07/12/2025, 04:49:29
- Last update
- 04/11/2026, 12:29:25
Track Janus Henderson Global Life Sciences Fund with an AI analyst
See which prediction-market events move JAGLX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
No news found for this symbol.